Bisphosphonates that lack a nitrogen-containing side chain do not cause osteonecrosis of the jaws, regardless of their effect on STAT3 phosphorylation and SOCS3 expression reply

被引：1

作者：

Reuben, Jayne S. ^{[1
]}

机构：

[1] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dallas, TX 75246 USA

来源：

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY | 2011年 / 112卷 / 06期

关键词：

CYTOKINE SIGNALING 3; OSTEOCLASTOGENESIS; MACROPHAGES; SUPPRESSOR; THERAPY; CANCER;

D O I：

10.1016/j.tripleo.2011.04.027

中图分类号：

R78 [口腔科学];

学科分类号：

100302 [口腔临床医学];

摘要：

引用

页码：707 / 708

页数：2

共 19 条

[1]

Bisphosphonates Cause Osteonecrosis of the Jaw-Like Disease in Mice [J].

Bi, Yanming ;

Gao, Yamei ;

Ehirchiou, Driss ;

Cao, Chunzhang ;

Kikuiri, Takashi ;

Le, Anh ;

Shi, Songtao ;

Zhang, Li .

AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (01) :280-290

[2]

Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma [J].

Brunello, Antonella ;

Saia, Giorgia ;

Bedogni, Alberto ;

Scaglione, Daniela ;

Basso, Umberto .

BONE, 2009, 44 (01) :173-175

[3]

SOCS3 negatively regulates IL-6 signaling in vivo [J].

Croker, BA ;

Krebs, DL ;

Zhang, JG ;

Wormald, S ;

Willson, TA ;

Stanley, EG ;

Robb, L ;

Greenhalgh, CJ ;

Förster, I ;

Clausen, BE ;

Nicola, NA ;

Metcalf, D ;

Hilton, DJ ;

Roberts, AW ;

Alexander, WS .

NATURE IMMUNOLOGY, 2003, 4 (06) :540-545

[4]

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma [J].

Henry, David H. ;

Costa, Luis ;

Goldwasser, Francois ;

Hirsh, Vera ;

Hungria, Vania ;

Prausova, Jana ;

Scagliotti, Giorgio Vittorio ;

Sleeboom, Harm ;

Spencer, Andrew ;

Vadhan-Raj, Saroj ;

von Moos, Roger ;

Willenbacher, Wolfgang ;

Woll, Penella J. ;

Wang, Jianming ;

Jiang, Qi ;

Jun, Susie ;

Dansey, Roger ;

Yeh, Howard .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) :1125-1132

[5]

Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases [J].

Hoefert, Sebastian ;

Eufinger, Harald .

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2010, 110 (04) :463-469

[6]

Osteonecrosis of the jaw related to sunitinib [J].

Koch F.P. ;

Walter C. ;

Hansen T. ;

Jäger E. ;

Wagner W. .

Oral and Maxillofacial Surgery, 2011, 15 (1) :63-66

[7]

The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy [J].

Kumar S.K.S. ;

Gorur A. ;

Schaudinn C. ;

Shuler C.F. ;

Costerton J.W. ;

Sedghizadeh P.P. .

Current Osteoporosis Reports, 2010, 8 (1) :40-48

[8]

SOCS3 regulates the plasticity of gp130 signaling [J].

Lang, R ;

Pauleau, AL ;

Parganas, E ;

Takahashi, Y ;

Mages, J ;

Ihle, JN ;

Rutschman, R ;

Murray, PJ .

NATURE IMMUNOLOGY, 2003, 4 (06) :546-550

[9]

Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation? [J].

Lesclous, Philippe ;

Najm, Semaan Abi ;

Carrel, Jean-Pierre ;

Baroukh, Brigitte ;

Lombardi, Tommaso ;

Willi, Jean-Pierre ;

Rizzoli, Rene ;

Saffar, Jean-Louis ;

Samson, Jacky .

BONE, 2009, 45 (05) :843-852

[10]

SOCS3 promotes TLR4 response in macrophages by feedback inhibiting TGF-β1/Smad3 signaling [J].

Liu, Xia ;

Zhang, Yongliang ;

Yu, Yizhi ;

Yang, Xiao ;

Cao, Xuetao .

MOLECULAR IMMUNOLOGY, 2008, 45 (05) :1405-1413

← 1 2 →